The vision to change the world 

Lifechanging therapy by global leaders in ophthalmology 

Eyerising International is an Australian MedTech company developing life-impacting eye-health therapy to slow the progression of myopia. We are led by a team of world-renowned ophthalmology academics, researchers and a board with a proven track record in MedTech innovation, implementation, and clinical facilitation.

Patented childhood myopia control therapy

Eyerising International’s Myopia Management Repeated Low-Level RedLight (RLRL) therapy was conceived and developed by ERI’s Chief Medical Officer, Professor Mingguang He, a global leader in myopia control and the development of artificial intelligence systems in ophthalmology. This innovation in childhood myopia control meets the quality, safety, and efficacy standards required by medical regulators in over 30 countries across Europe and Australasia.

View our most important scientific papers 

News and press releases

A Game-Changer in Myopia Management is Now Available in Malaysia

July 11, 2024|

We are excited to announce that our new partner in Malaysia, Transmedic Ophthalmology, will be launching and showcasing the Eyerising Myopia Management Device at the World Congress of Paediatric Ophthalmology and Strabismus (WCPOS) in Kuala[...]

Mark your calendars for July 12!

July 1, 2024|

Join us at the World Congress of Paediatric Ophthalmology and Strabismus, breakfast symposium for an insightful panel discussion on Repeated Low-Level Red-Light Therapy for Myopia, featuring a panel of world-class experts. Don't miss this opportunity[...]

3rd Ho Chi Minh City Ophthalmology Conference 2024

June 28, 2024|

With an aim to provide a solution to the increasing number of children with myopia, we are proud to introduce Repeated Low-Level Red-Light Therapy (RLRL) in Vietnam. We will be attending the 3rd Ho Chi[...]

Professor Mingguang He

Founder, Chief Medical Officer

Prof. He has over 25 years of experience in ophthalmology. He is currently a Professor of Ophthalmic Epidemiology at the University of Melbourne and leads ophthalmic epidemiology research at the Centre for Eye Research Australia. His research has led to original articles and invited editorials in respected medical journals, including the Journal of the American Medical Association, Diabetes Care, & Ophthalmology.

Jason Sun

Founder, MD

With a clinical background and over 20+ years of executive experience in the Australian health sector, including 10 years of industry development experience, Mr. Sun brings expertise in Medtech commercialisation, international business, regulatory compliance, and government relations.   

Michael Woods

Executive Director

Mr. Woods has been an investor, adviser, board member, and CEO for various life science start-ups and scale-up companies in the life sciences sector.

Manny Pascual

Head of Commercial

Over 20 years of experience in the medical device industry Previous Marketing Director for CooperVision Asia Pacific Previous success in medical device company business expansion and acceleration.

David Holland

Business Development Manager (Australasia)

Federico Roma

CTO Accomplished technology leader

Dr. Yuri Aung

Clinical Affairs and RAQA Manager

Dr. Lisa Zhuoting Zhu

Director of Clinical Development

For any investor questions, please send your queries to:

Email: info@eyerisinginternational.com

Eyerising International Pty Ltd

Head office

Suite 2.05
9/11 Claremont St
South Yarra VIC 3141